Document is current
Any future updates will be listed below
-
Authors
Dardis, A. https://orcid.org/0000-0001-7024-8181
Michelakakis, H.
Rozenfeld, P.
Fumic, K.
Wagner, J.
Pavan, E.
Fuller, M.
Revel-Vilk, S.
Hughes, D.
Cox, T.
Aerts, J.
,
- License Information
-
More Information
Article History
Received: 14 July 2022
Accepted: 20 November 2022
First Online: 21 December 2022
Declarations
:
: Not applicable.
: Not applicable.
: AD received consulting fees, speaker honoraria and research grants from Amicus, Takeda and Sanofi. PR have received consulting and research grants from Takeda, Biomarin and Amicus. EP received a doctoral fellowship from Sanofi. MF received research and travel funds from Abeona Therapeutics, Paradigm Biopharmaceuticals, Sanofi, Takeda and Taysha Gene Therapies. SR-V received research support/honoraria from Sanofi, Takeda and Pifzer. DH performed consultancy work and speaking engagements through UCL consultants for Takeda, Sanofi and Freeline. TC advises AvroBio, Sanofi, Takeda and receives honoraria for ABPI approved lectures. University of Cambridge has received research funds from Takeda and Sanofi to support investigator-led studies in Gaucher disease. Cambridge University hospitals receives fees from Sanofi for the conduct of a clinical trial in Gaucher disease.
